EMBECTA CORP.

EMBC ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Revenue $1.08B $1.12B $1.12B $1.13B $1.17B $1.09B
Cost of Revenue $403.6M $387.9M $370.9M $354.6M $364.9M $322.9M
Gross Profit $676.8M $735.2M $749.9M $774.9M $800.4M $762.6M
Gross Margin 62.6% 65.5% 66.9% 68.6% 68.7% 70.3%
Operating Expenses
Research & Development $37.3M $78.8M $85.2M $66.9M $63.3M $61.4M
SG&A Expense $332.0M $365.1M $341.3M $294.8M $240.3M $214.7M
Operating Income $242.1M $166.8M $221.5M $309.6M $492.0M $486.5M
Operating Margin 22.4% 14.9% 19.8% 27.4% 42.2% 44.8%
Interest Expense
Pretax Income $136.3M $44.2M $105.7M $256.6M $494.9M $485.8M
Income Tax Expense $40.9M $-34.1M $35.3M $33.0M $80.1M $58.2M
Net Income $95.4M $78.3M $70.4M $223.6M $414.8M $427.6M
Net Margin 8.8% 7.0% 6.3% 19.8% 35.6% 39.4%
EPS (Basic) $1.64 $1.36 $1.23 $3.92 $7.28 $7.50
EPS (Diluted) $1.62 $1.34 $1.22 $3.89 $7.28 $7.50
Shares Outstanding (Basic) 58.3M 57.7M 57.2M 57.0M 57.0M 57.0M
Shares Outstanding (Diluted) 58.9M 58.3M 57.8M 57.5M 57.0M 57.0M
Dividends Per Share $0.60 $0.60 $0.60 $0.15